Guglielmini, P., A. Serao, S. Zai, P. Piovano, and F. Grosso. “Second-Line Treatment With Axitinib: An Effective and Well-Tolerated Weapon in the Therapeutic Sequence of Clear Cell Renal Cell Carcinoma”. Working Paper of Public Health, vol. 4, no. 1, June 2015, doi:10.4081/wpph.2015.6697.